Home
/ DCprime
/ Competitors

DCprime Competitors and Similar CompaniesClear all

DCprime's competitors and similar companies include GlycoMimetics, LiPlasome Pharma, TRACON Pharmaceuticals and Biomarck.

	DCprime DCprime is a company developing cancer vaccines.	GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.	LiPlasome Pharma LiPlasome Pharma is a biotech company focused on oncology.	TRACON Pharmaceuticals TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration.	Biomarck Biomarck is a biopharmaceutical company with a patented technology platform.
Founding Date	Founding Date 2005	Founding Date 2003	Founding Date 2002	Founding Date 2006	Founding Date 2002
Type	Type Private	Type Public	Type Subsidiary	Type Public	Type Private
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Leiden, NL HQ	Locations Rockville, US HQ	Locations Hørsholm, DK HQ	Locations San Diego, US HQ	Locations Newtown, US HQ
Employees	Employees 26	Employees 5025% increase	Employees 13	Employees 268% increase	Employees 1115% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 31.6 m	Valuation ($) N/A	Valuation ($) 279.4 k	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $10.8m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $12m (FY, 2023)	Revenue (est.) N/A
Net income	Net income N/A	Net income ($153.9m) (FY, 2025)	Net income N/A	Net income ($3.6m) (FY, 2023)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 101.8m	Total funding raised $ 8m	Total funding raised $ 41m	Total funding raised $ 751.3k